OptimizeRx Corp — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2020-09-30

Reporting Person: WASSON GREGORY D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-30	Common Stock	A	1183	—	Acquired	16183	Direct
2020-12-31	Common Stock	A	802	—	Acquired	16985	Direct

Footnotes

F1: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan.